about
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.Parallel appearance of compulsive behaviors and artistic creativity in Parkinson's diseasePersonality traits and brain dopaminergic function in Parkinson's diseaseExpectation of caffeine induces dopaminergic responses in humans.Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function.Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.Dopaminergic function and intertemporal choice.Intravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [(11)C]raclopride.Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairmentClinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation.Brain function during multi-trial learning in mild cognitive impairment: a PET activation study.Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease.Predictors of normal and abnormal outcome in clinical brain dopamine transporter imaging.Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.[Phenotype and incidence of Creutzfeldt-Jakob disease in Finland in 1997-2013].Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease.Hypermetabolism of Olivary Nuclei in a Patient with Progressive Ataxia and Palatal Tremor.Unlike in clinical blindsight patients, unconscious processing of chromatic information depends on early visual cortex in healthy humans.Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.Akinetic crisis in Parkinson's disease is associated with a severe loss of striatal dopamine transporter function: a report of two cases.Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient.Diagnostic accuracy of parkinsonism syndromes by general neurologists.Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia.Age-related loss of extrastriatal dopamine D(2) -like receptors in women.Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study.Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease.Dopaminergic effects of caffeine in the human striatum and thalamus.Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease.Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily.The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [11C]MADAM.Pharmacotherapy and generic health-related quality of life in Parkinson's disease.Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration.
P50
Q31158920-E8D30DB6-FD60-477C-B719-76E207CE50D9Q33454788-2AACC32E-C7BA-45A4-8F97-3A6FF658536DQ33949298-8326F8A5-8EC5-40C8-8AE0-B23B489F9847Q34314230-B9DAF98B-F414-4BE4-A5DA-F69265E85DEEQ34787741-B2593CC1-FA3B-4935-BC9C-70F42C137121Q35019301-0A5E3D33-59A4-4F61-A7F3-0C436EAFE3D9Q35034782-D8F5B7C9-CE94-4631-813F-2659FDFC99D1Q35143469-6995EC0E-1150-4083-A5CF-54DF7D589D45Q35477186-9ABAAD81-5DF3-4ABA-B22C-7BF9720B1020Q36738606-510CF087-CAB6-47D1-8FA4-6ACD15B84F9DQ38400776-5980B714-59A1-427F-BDD8-06470B44935EQ40090298-DF458F19-3375-466C-BD7C-FBAA5644ADE6Q40202710-FDE53A30-3237-4B63-AA4E-88610EEE5035Q41168131-D3DEDC83-30CB-4F45-9B8B-57FDB364366EQ41519166-3DA3563A-8BFA-4CAD-9638-6BF6CA9B81E1Q41654754-2510F212-11B0-4C90-B768-BCA851728637Q41865144-3C79CEF8-EE08-4A95-AD58-BE84D90B7B5CQ42179658-38A173C0-166E-4F98-A229-E1247BE63F0BQ42652267-5E8E373B-67F0-49CA-9967-033B92DA621FQ43080302-CE512BBB-525A-4E08-B1B4-DA154A2F6FECQ43086114-473B4A76-57C6-4007-B7D4-BEDF8FC12903Q43162033-AA3EB5DE-BA03-4FFE-B5E2-635EC68364CDQ43550833-7695565B-C2E2-4F19-BC4D-30BBB6FE1D07Q43608350-D012ADD3-1FC2-43C3-A4DC-49384A2548C5Q44009309-AAAB87EA-FDEC-4673-819D-AEC77476E536Q44028697-731AE821-8A6A-47D8-B3A5-4D037A9D83FCQ44231414-ACE17700-E848-431F-B35D-784BCA462D50Q44455086-4B710AFB-A72B-4530-81B1-79A027F4D0E1Q44511971-1BE6E23F-207C-4FD4-AF6B-1A27D87F0A1BQ44704449-D9EF7901-3F73-4946-A29E-A96B170A124DQ44761896-0B720F56-AC74-40B6-8BE0-B0C3CFA4EF72Q44839019-89B86A70-C737-4984-9530-CD2BE2468CA0Q45076624-1EB6FA8A-6F0A-4FA4-89DD-25A77297349AQ46116294-F6B4FE12-A7D5-44A8-9D5C-12BEA7B0F63EQ46263889-759BBCEA-7218-44AD-882D-18F0463962DBQ46750528-2869882E-1D18-42D8-A7C5-AE782F998C4EQ47373845-62BFA83A-1830-48D4-8ADB-40A140ACC08EQ47739149-13851564-5224-4701-86ED-494F6BECE0BAQ47914989-58A3450B-E277-4531-9A8A-3C94EE5FD559Q48134704-BD8D996C-1579-483D-90EB-E40B959E17DE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valtteri Kaasinen
@ast
Valtteri Kaasinen
@en
Valtteri Kaasinen
@es
Valtteri Kaasinen
@nl
Valtteri Kaasinen
@sl
type
label
Valtteri Kaasinen
@ast
Valtteri Kaasinen
@en
Valtteri Kaasinen
@es
Valtteri Kaasinen
@nl
Valtteri Kaasinen
@sl
prefLabel
Valtteri Kaasinen
@ast
Valtteri Kaasinen
@en
Valtteri Kaasinen
@es
Valtteri Kaasinen
@nl
Valtteri Kaasinen
@sl
P1053
O-2086-2016
P106
P21
P2456
P31
P3829
P4012
P496
0000-0002-3446-7093
P569
2000-01-01T00:00:00Z